True to Life
Elevating the standard of care to live fulfilling lives
At Olympus we believe everyone should have the opportunity to live a fulfilling life. Every day we develop and deliver medical technology solutions that elevate the standard of healthcare throughout the patient pathway, but most of all to help people everywhere fulfill their desires, their curiosity, their dreams, their ambition, and their lives.
It’s a philosophy we call: True to Life
True to patient care. True to LIFE.
On April 1, 2022, the Life Science Solutions and Industrial Solutions businesses transitioned to Evident Corporation, a wholly owned subsidiary of Olympus. With this transition, there will be no change to the products or level of service and support you have come to expect.
Olympus Announces Exclusive U.S. Co-Marketing Agreement with Bracco Diagnostics, Inc.
Through this agreement, Olympus and Bracco Diagnostics Inc. will work together to raise awareness of the role of endoscopic ultrasound (EUS) with contrast in the characterization of focal liver lesions.
Study Results Show Long-term Efficacy of iTind Procedure
Abstract of Durability Study Results for iTind Procedure Presented at 2022 American Urological Association Annual Meeting
Coding for Minimally Invasive Endoscopic Treatments Are Now Available
Olympus supports the recent creation of new reimbursement billing codes for Per-oral Endoscopic Myotomy (POEM) Endoscopic Submucosal Dissection (ESD) procedures; Decision is expected to improve patient access to the minimally invasive procedure